Home/Investors/Alexandria Venture Investments

Alexandria Venture Investments

Biotech Investor · 8 portfolio companies

Portfolio

8

Focus Areas

15

Top Stage

preclinical

Investment Focus

Immunology Rare Disease Allergy Migraine Metabolic Disorders Oncology Metabolic Autoimmune Diseases Inflammatory Diseases Hematology Cell Therapy Regenerative Medicine Genetic Diseases Metabolic Diseases Gastroenterology

Portfolio Companies

Company	Stage	Valuation	Focus
IgGenix	phase-2	—	Immunology, Rare Disease
Kallyope	Phase 2	—	Migraine, Metabolic Disorders
PIC Therapeutics	Pre-clinical	—	Oncology, Metabolic
Sonoma Biotherapeutics	Phase 1	—	Autoimmune Diseases, Inflammatory Diseases
Garuda Therapeutics	preclinical	—	Hematology, Cell Therapy
Seismic Therapeutic	preclinical	—	Immunology, Autoimmune Diseases
Senda Biosciences	platform	—	Genetic Diseases, Metabolic Diseases
Borealis Biosciences	preclinical	—	Metabolic, Gastroenterology

Frequent Co-Investors

Flagship Pioneering2 shared Polaris Partners2 shared Osage University Partners2 shared 5AM Ventures1 shared Frazier Life Sciences1 shared ARCH Venture Partners1 shared GV1 shared The Column Group1 shared